Tzelepi, V.; Gika, H.; Begou, O.; Timotheadou, E. The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review. Int. J. Mol. Sci.2023, 24, 13961.
Tzelepi, V.; Gika, H.; Begou, O.; Timotheadou, E. The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review. Int. J. Mol. Sci. 2023, 24, 13961.
Tzelepi, V.; Gika, H.; Begou, O.; Timotheadou, E. The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review. Int. J. Mol. Sci.2023, 24, 13961.
Tzelepi, V.; Gika, H.; Begou, O.; Timotheadou, E. The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review. Int. J. Mol. Sci. 2023, 24, 13961.
Abstract
Lipidomics provides comprehensive study of all lipid components in cells, serum, plasma or tissues of organisms, aiming to the discovery of diagnostic, prognostic and predictive biomarkers of diseases such as malignancies. This systematic review evaluates studies, where lipidomics applies to the diagnosis, prognosis, prediction of ovarian cancer (OC) and the discrimination between malignant and benign ovarian masses. Literature search was conducted in PubMed, Science Direct and SciFinder. Only publications written in English language after 2012 were included. From the reference lists of primary included studies, relevant citations were identified and were also added in our list. All studies included referred to the application of lipidomics in serum/plasma samples of human cases with OC, whereby few of them included also tumor tissue samples. In some of the included studies metabolomic analysis was also involved where other metabolites besides lipids were identified. Qualitative data were assessed and risk of bias was determined using the ROBINS-I tool. In total, 29 studies were included, 15 of which applied non-targeted, 7 targeted lipidomics and 7 were reviews relevant to our aim. Most studies concerned the possible application of lipidomics in OC diagnosis, exhibiting phospholipids and sphingolipids as the most significantly altered during development of the disease. In conclusion, this systematic review highlights the potential contribution of lipids as biomarkers in OC management.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
